Jibin Li
State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Matching-adjusted indirect comparison of fruquintinib versus ramucirumab in advanced gastric or gastroesophageal junction adenocarcinoma.
Journal: Journal of comparative effectiveness research
Published: August 12, 2026
Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial.
Journal: JAMA
Published: August 10, 2026
A Surgical Map Defining High-Risk Anatomical Boundaries for Salvage Endoscopic Nasopharyngectomy.
Journal: The Laryngoscope
Published: May 21, 2026
Tislelizumab Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Phase II Trial (EC-CRT-002).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 10, 2026
Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical Cancer.
Journal: The New England journal of medicine
Published: October 15, 2025
Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 26, 2025
Fibrin sealant for prophylaxis of cervical anastomotic leakage after McKeown esophagectomy for esophageal or esophagogastric junction cancer (PLACE030): a Phase III multicenter randomized clinical trial.
Journal: International journal of surgery (London, England)
Published: July 09, 2025
Durvalumab plus HAIC-FOLFOX followed by maintenance durvalumab for hepatocellular carcinoma with major portal invasion: phase 2 DurHope study.
Journal: Nature communications
Published: June 24, 2025
Olanzapine combined with standard antiemetics for the prevention of nausea and vomiting in patients with germ cell tumor undergoing a 5-day cisplatin-based chemotherapy (NAVIGATE study)： A phase III crossover trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 07, 2025
Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial.
Journal: Signal transduction and targeted therapy
Published: November 25, 2024
Comparing PD-L1 with PD-1 antibodies combined with lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: September 05, 2024
Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study.
Journal: Signal transduction and targeted therapy
Published: August 26, 2023
Last Updated: 09/26/2026